Literature DB >> 24613087

Investigation of FGF1 and FGFR gene polymorphisms in a group of Iranian patients with nonsyndromic cleft lip with or without cleft palate.

Zahra Rafiqdoost1, Amir Rafiqdoost2, Houshang Rafiqdoost3, Mohammad Hashemi4, Jina Khayatzadeh1, Ebrahim Eskandari-Nasab5.   

Abstract

OBJECTIVE: Nonsyndromic cleft lip with or without cleft palate (NS-CL/P) is one of the most common craniofacial malformations determined by the interaction between multiple genes and environmental risk factors. Genes coding for fibroblast growth factors and their receptors (FGF/FGFR genes) are considered as excellent candidate genes, which their proteins play important roles in craniofacial and palatal development. The aim of the current study was to assess the possible association between FGF1 rs34010 C>A and FGFR1 rs13317 A>G gene polymorphisms and susceptibility to NS-CL/P in an Iranian population.
DESIGN: This case-control retrospective study was performed on a total of 200 subjects including 100 NS-CL/P patients and 100 healthy unrelated controls. Tetra amplification refractory mutation system-polymerase chain reaction (T-ARMS-PCR) was used to detect FGF1 rs34010 C>A and FGFR1 rs13317 A>G SNPs.
RESULTS: Our data demonstrated that the FGF1 rs34010, CA and CA+AA genotypes were associated with a reduced risk of NS-CL/P the in codominant (CA vs. CC: OR=0.29, 95%CI=0.16-0.55, P=0.001) and dominant (CA+AA vs. CC: OR=0.36, 95%CI=0.19-0.69, P=0.001) tested inheritance models, respectively. Additionally, the analysis of FGF1/FGFR1 genotype combinations revealed that rs34010CA/rs13317AA and rs34010CA/rs13317AG combinations were associated with a lower risk of NS-CL/P (OR=0.357, P=0.008 for the rs34010CA/rs13317AA; OR=0.226, P=0.004 for the rs34010CA/rs13317AG).
CONCLUSIONS: Our findings suggest that the FGF1 rs34010 C/A polymorphism was associated with a decreased risk of NS-CL/P, and might act as a protective factor against NS-CL/P predisposition.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cleft lip and/or cleft palate; FGF1; FGFR1; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2014        PMID: 24613087     DOI: 10.1016/j.ijporl.2014.01.024

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  5 in total

1.  Association between the FGFR1 rs13317 single nucleotide polymorphism and orbitale-nasion depth based on cephalometric images.

Authors:  Mohamed Adel; Tetsutaro Yamaguchi; Daisuke Tomita; Yong-Il Kim; Masahiro Takahashi; Takatoshi Nakawaki; Yu Hikita; Shugo Haga; Mohamed Nadim; Akira Kawaguchi; Mutsumi Isa; Walid El-Kenany; Abbadi A El-Kadi; Soo-Byung Park; Hajime Ishida; Koutaro Maki; Ryosuke Kimura
Journal:  J Hum Genet       Date:  2018-06-05       Impact factor: 3.172

2.  Contribution of FGFR1 Variants to Craniofacial Variations in East Asians.

Authors:  Mohamed Adel; Tetsutaro Yamaguchi; Daisuke Tomita; Takatoshi Nakawaki; Yong-Il Kim; Yu Hikita; Shugo Haga; Masahiro Takahashi; Mohamed A Nadim; Akira Kawaguchi; Mutsumi Isa; Walid H El-Kenany; Abbadi A El-Kadi; Soo-Byung Park; Hajime Ishida; Koutaro Maki; Ryosuke Kimura
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

3.  The Evaluation of FGFR1, FGFR2 and FOXO1 in Orofacial Cleft Tissue.

Authors:  Jana Goida; Mara Pilmane
Journal:  Children (Basel)       Date:  2022-04-06

4.  Associations between microRNA binding site SNPs in FGFs and FGFRs and the risk of non-syndromic orofacial cleft.

Authors:  Dandan Li; Hongchuang Zhang; Lan Ma; Yue Han; Min Xu; Zhendong Wang; Hongbing Jiang; Weibing Zhang; Lin Wang; Yongchu Pan
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

5.  Association of single nucleotide polymorphisms in AXIN2, BMP4, and IRF6 with Non-Syndromic Cleft Lip with or without Cleft Palate in a sample of the southeast Iranian population.

Authors:  Houshang Rafighdoost; Mohammad Hashemi; Hiva Danesh; Fatemeh Bizhani; Gholamreza Bahari; Mohsen Taheri
Journal:  J Appl Oral Sci       Date:  2017 Nov-Dec       Impact factor: 2.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.